Sars Test N Protein Results

Human IgG Quick test strip

E411A02-10 10 tests
EUR 150

Human IgG antibody Laboratories manufactures the sars test n protein results reagents distributed by Genprice. The Sars Test N Protein Results reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact SARS Test. Other Sars products are available in stock. Specificity: Sars Category: Test Group: N Protein

Human Tuberculosis IgG (TB IgG) Rapid Test Kit

200 µl
EUR 350

Human Toxoplasma IgG (TOXO IgG) Rapid Test Kit

100 µl
EUR 225

Human Toxoplasma IgG (TOXO IgG) Rapid Test Kit

1 ml Ask for price

Human Toxoplasma IgG (TOXO IgG) Rapid Test Kit

200 µl
EUR 350

Human Cytomegalovirus IgG (CMV IgG) Rapid Test Kit

100 µl
EUR 225

Human Cytomegalovirus IgG (CMV IgG) Rapid Test Kit

1 ml Ask for price

Human Cytomegalovirus IgG (CMV IgG) Rapid Test Kit

200 µl
EUR 350

N Protein information

TruStrip RDT Cow/Bovine Infectious rhinitis (IBR) antibody rapid test card, results is 2-10 mins, 50 cards/pk

RV-500300-RDT 1 pk Ask for price

TruStrip RDT Canine distemper virus (hardpad disease) antigen rapid test card, results is 2-10 mins, 50 cards/pk

RV-501200-RDT 1 pk Ask for price

TruStrip RDT Human Anti-Zaire Ebola virus glycoprotein (GP) antibody rapid test (visual results in 2-10 min), 10 cassettes/pk

AE-320625-RDT 1 pk
EUR 351.6

TruStrip RDT Humanized Ebola IgG (humanized IgGs expressed in tobacco or other plants) rapid test (results in 2-10 min), 25 cassettes/pk

AE-320880-RDT-25 1 pk
EUR 351.6

Multiple organs tumor tissue array, including pathology grade, TNM, clinical stage IHC markers (ER, PR, Her-2) results, 118 cases/208 cores

BR20838 row: 13; column: 16; cores: 208; cases: 118
EUR 474
Description: Multiple organs tumor tissue microarray, containing 80 cases of breast invasive carcinoma of no special type, 10 cancer adjacent breast tissue, duplicate cores per case, 4 ovary serous adenocarcinoma, 4 uterus endometrioid adenocarcinoma, 6 rectum adenocarcinoma, 6 colon adenocarcinoma, 2 esophagus squamous cell carcinoma, 2 stomach carcinoma, 2 pancreas adenocarcinoma, 2 lung carcinoma, single core per case

Breast tumor tissue array (18 of 25), including pathology grade, TNM, clinical stage and IHC markers (ER, PR, Her-2) results,104 cases/208 cores

BR20824 row: 13; column: 16; cores: 208; cases: 104
EUR 474
Description: Breast tumor tissue microarray (slide 18 of 2600 cases of breast cancer survey slide set), containing 83 cases of invasive carcinoma of no special type, 4 mucinous carcinoma, 9 medullary carcinoma, 6 invasive lobular carcinoma, 1 each of apocrine carcinoma and cystosarcoma phyllodes, duplicate cores per case

Breast cancer tissue array with normal breast tissue, including pathology grade, TNM, clinical stage and Her-2 results, 5 cases/5 cores

BRC051 row: 1; column: 5; cores: 5; cases: 5
EUR 42
Description: Breast invasive carcinoma of no special type microarray, containing 4 casee of breast invasive carcinoma of no special type and 1 normal breast tissue, single core per case

anti- SARS antibody

FNab07609 100µg
EUR 658.5
Description: Antibody raised against SARS

Breast invasive carcinoma of no special type tissue array, including pathology grade, TNM, clinical stage and IHC markers (PR, Ki-67, Her-2) results, 10 cases/10 cores

FMG010 row: 3; column: 4; cores: 10; cases: 10
EUR 78
Description: Breast invasive carcinoma of no special type tissue microarray, containing 10 cases of breast invasive carcinoma of no special type, single cores per case

SARS-CoV-2 Antigen Rapid Test

INCP-502H 25 Tests
EUR 8.75

Breast cancer tissue array (most of triple negative), including pathology grade, TNM, clinical stage and IHC markers (ER, PR, Her-2) results, 60 cases/120 cores, replacing BR1201a

BR1201b row: 10; column: 12; cores: 120; cases: 60
EUR 354
Description: Breast carcinoma tissue microarray (most of triple negative), containing 56 cases invasive carcinoma of no special type, 2 cases invasive papillary adenocarcinoma, 1 each of medullary carcinoma and apocrine carcinoma, duplicate core per case

Breast cancer tissue array (most of Her-2 subtype), including molecular typing, pathology grade, TNM and clinical stage, with IHC results of ER, PR and Her-2, 50 cases/150 cores

BR1510 row: 10; column: 15; cores: 150; cases: 50
EUR 354
Description: Breast carcinoma tissue microarray, containing 45 cases of invasive carcinoma of no special type, 2 medullary carcinoma, 1 each of metaplastic carcinoma, mixed carcinoma and apocrine carcinoma, triplicate cores per case

Breast cancer with adjacent normal breast tissue array, including pathology grade, TNM, clinical stage and IHC marker (ER, PR, Her2, Ki-67) results, 72 cases/72 cores, replacing BC08013d

FMG08013e row: 8; column: 9; cores: 72; cases: 72
EUR 168
Description: Breast carcinoma with adjacent normal breast tissue microarray, containing 63 cases of invasive carcinoma of no special type, 6 medullary carcinoma, 3 adjacent normal breast tissue, single core per case

SARS-CoV-2 Antigen Rapid Test Kit

CoV2Ag-1 1T
EUR 9.6
Description: This kit adopts the sandwich method and the technical principle of colloidal gold immunochromatography to qualitative determine the SARS-CoV-2 antigen. During the test, the sample is dropped into the sample well, and chromatography is performed under the capillary effect. The SARS-CoV-2 antigen in the sample combined with the colloidal goldlabeled SARS-CoV-2 monoclonal antibody I, and then spread to the test area. It is captured by another coated antibody (SARS-CoV-2 monoclonal antibody II), to form a complex and gather in the test area (T line). The quality control area is coated with the goat antimouse antibody, and the colloidal gold-labeled antibody is captured to form a complex and aggregate in the quality control area (C line). If the C line does not show color, it indicates that the result is invalid, and this sample needs to be tested again.

SARS-CoV-2 Antigen Rapid Test Kit

CoV2Ag-25 25T/kit
EUR 42
Description: This product is used for in vitro qualitative detection of SARS-CoV-2 antigen in human oropharyngeal swabs, nasal swabs and nasopharyngeal swabs. It is helpful as an aid in the screening of early mild, asymptomatic, or acute patients for identification of SARS-CoV-2 infection.

SARS-CoV-2 Antigen Rapid Test Kit

abx294181-100g 100 µg
EUR 850

SARS-CoV-2 Antigen Rapid Test Kit

abx294181-20g 20 µg
EUR 100
Copyright © 2024 Interleukin 12
Theme by Pro